Sep 22, 2016 at 22:19 | Source: CNBC-TV18
I am taking this as a second round of up move on anticipation of very good numbers to be seen from all of them and more specially if you need to put me in the pecking order probably I will go with Ujjivan, Capital First and then the Equitas Holding, said SP Tulsian.
Sep 20, 2016 at 14:58 | Source: PTI
The US Food and Drug Administration (USFDA) has placed Laxachem Organics Pvt Ltd on import alert 99-32 that allows detention without physical examination of products from firms refusing FDA foreign establishment inspection, FDA said on its website.
Sep 20, 2016 at 11:09 | Source: CNBC-TV18
The company had received warning letters for Moraiya and Zyfine plants in December last year. Zyfine facility, however, will take another 3-4 moths for remediation, sources say.
Sep 19, 2016 at 14:56 | Source: CNBC-TV18
Surajit Pal, Pharma Analyst at Prabhudas Lilladher told CNBC-TV18 that this is good news for Aurobindo as this plant has almost 26 percent of pending approvals which are important drivers for its US business.
Sep 16, 2016 at 14:44 | Source: CNBC-TV18
The US Food and Drug Administration (FDA) has given a clean chit to the Chikalthana plant of Wockhardt, reports CNBC Awaaz quoting sources. Official announcement from the FDA is expected in couple of weeks.
Sep 09, 2016 at 20:20 | Source: PTI
Drug firm Caplin Point Laboratories today said US health regulator would conduct a prior approval inspection of its Gummidopoondi facility in Chennai in October.
Sep 07, 2016 at 16:07 | Source: CNBC-TV18
US FDA inspected the Goa plant II for five days starting from August 31. Injectable Abbreviated New Drug Application (ANDA) filings had triggered the US FDA to inspect the plant.
Sep 01, 2016 at 16:16 | Source: PTI
Gavis has received tentative approval for its Azithromycin for oral suspension USP from the United States Food and Drug Administration (FDA), Lupin said in a BSE filing.
Aug 27, 2016 at 18:30 | Source: PTI
Drug firm Claris Lifesciences has received approval from the US health regulator for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the America market.
Aug 26, 2016 at 15:58 | Source: Reuters
This is one of a series of quality concerns tied to the Philadelphia, Pennsylvania factory that the FDA highlighted in an Aug. 15 "warning letter" issued to the site's current owner, US firm Frontida BioPharm Inc.
Messages on Fda »


Platinum Member


Amtek Auto  

Thanks for your information please. A few days back, ET had reported Wockhard got FDA clearance, you can see in Wockhard board. I am not saying your information is wrong, but when huge money is involved, there goes no shortage of paid news. However, please act as you find OK.

12.47 PM Sep 26th


New Member


Sharon Bio Medi  

After getting US FDA nod see marksan pharma is up by 12%....!!! It will be 15 very soon in this week....!!!

12.30 PM Sep 26th


Platinum Member



EMA turnaround is usually faster than FDA; FY18 will be very interesting for Biocon from that sense as well; of course EM sales from Malaysia will be in H2FY17 numbers; 600 FV=1 in 2 years from now sounds possible to me!

6.31 PM Sep 25th


New Member



buy kopran for a upper circuit the company has received an usa fda approval today sure

12.16 PM Sep 23rd


New Member


Morepen Laboratories  

now....definetlythis stock will give you fruits in longterm....just look at its all time heigh and compare with its present god...its really showing a great already got fda approval...and again needs to be got suggestion is to buy and hold for long

10.35 AM Sep 23rd


New Member


Syncom Health  

buy sharon bio at 12.75 for a target of rs 30 it has got us fda approval for its plant devbalayan don`t miss it

10.16 AM Sep 23rd


Silver Member


Sharon Bio Medi  

After inspection and audit by US FDA team in Jul 2015, the scrip was quoted above 20/- and in Dec touched its high of 32/-, scrip should be at least 22-24 after getting FDA nod for the plant. UC may continue in afternoon.

10.15 AM Sep 23rd


Platinum Member



Wockhardt as a Anand Rathi Sales Note states has received Establishment Inspection Report EIR The report is for its Chikalthana facility for its March 2015 US Food and Drug Administration FDA inspection Upon completion of inspection USFDA provides inspected establishments an inspection

9.57 PM Sep 22nd


New Member



dna india : us fda has cleared wockhardt`s kadaiya facility at daman, said chairman habil khorakiwala. "our kadaiya facility at daman has been cleared by the us fda. it stays in full compliance," khorakiwala told reporters. in october 2013, fda had imposed restrictions on import of medicines made

4.12 PM Sep 22nd


Platinum Member


Sharon Bio Medi  

they just got eir approval for facotry have they got patent right to manufacture the product atleaset some anda filling . kindly note that once in two years u need to get FDA inspection.. what is the guarantee that in the coming inspection they will get zero observation report

3.54 PM Sep 22nd

News across the web »
Aug 26, 2016 at 18:38 | Source: FirstPost
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.